JSPR Tiesioginiai signalai | Didinkite pelną su Getagraph.com

PARDAVIMAS 119276 min ago

@ $17.42

Išleistas: 9 vas. 2024 @ 20:49

Grąža: 36.07%

Ankstesnis signalas: vas. 8 - 18:44

Ankstesnis signalas: Pirkimas

Grąža: 5.05 %

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 17:43):

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies...

Stats
Šios dienos apimtis	15 062.00
Vidutinė apimtis	115 626
Rinkos kapitalizacija	357.53M
EPS	$0 ( 2024-03-13 )
Kita pelno data	( $-1.200 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.380
ATR14	$0.127 (0.54%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-12	Mahal Jeetinder Singh	Buy	900	Voting Common Stock
2024-03-12	Mahal Jeetinder Singh	Sell	900	Voting Common Stock
2024-03-12	Mahal Jeetinder Singh	Buy	900	Stock Option (right to buy)
2024-02-15	Martell Ron	Buy	100 000	Stock Option (right to buy)
2024-02-15	Mahal Jeetinder Singh	Buy	40 000	Stock Option (right to buy)

INSIDER POWER
91.96
Last 82 transactions
Buy: 17 940 158 \| Sell: 1 631 987

Tūris Koreliacija

Ilgas: -0.07 (neutral)

Trumpas: 0.43 (neutral)

Signal:(37.603) Neutral

Jasper Therapeutics, Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
SCR	0.947
PAIC	0.946
SRRA	0.928
SVAC	0.92
CMPO	0.915
ICON	0.912
TLGT	0.91
PAE	0.908
KIN	0.908
CRVL	0.907

10 Labiausiai neigiamai susiję koreliacijos
NETE	-0.947
LCAP	-0.939
VTIP	-0.924
AMRB	-0.915
OP	-0.901
RAVN	-0.899
MMAC	-0.898
NAKD	-0.896
NRBO	-0.896
PCSA	-0.895

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Jasper Therapeutics, Inc. Koreliacija - Valiuta/Žaliavos

-0.29
( neutral )

-0.61
( weak negative )

-0.43
( neutral )

0.86
( strong )

0.23
( neutral )

Jasper Therapeutics, Inc. Finansinės ataskaitos

Annual	2023
Pajamos:	$0
Bruto pelnas:	$-1.11M (0.00 %)
EPS:	$-6.18

FY	2023
Pajamos:	$0
Bruto pelnas:	$-1.11M (0.00 %)
EPS:	$-6.18

FY	2022
Pajamos:	$0
Bruto pelnas:	$-1.31M (0.00 %)
EPS:	$-6.63

FY	2021
Pajamos:	$0.00
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$-2.69

Financial Reports:

No articles found.

Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The company's lead product candidate is JSP191, which is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.